Leen Ibrahim sabbagh
Dubai medical university , United Arab EmaritisPresentation Title:
Robotic-Assisted Surgery in Ovarian Cancer: Advancements, Oncologic Outcomes, and Challenges
Abstract
Ovarian cancer is one of the leading causes of gynecologic cancer-related mortality worldwide. Traditional surgical management has evolved with the introduction of robotic-assisted surgery (RAS), which aims to enhance precision, reduce complications, and improve patient outcomes. While RAS is becoming more widely adopted, its true oncologic benefits, cost-effectiveness, and long-term outcomes remain under debate. This systematic review critically examines the existing literature to assess the efficacy, safety, and oncologic impact of RAS in ovarian cancer management.
Methods: A comprehensive literature search was conducted across PubMed, Embase, and the Cochrane Library, including publications up to February 2025. The inclusion criteria focused solely on systematic reviews evaluating RAS in ovarian cancer treatment. Data extraction targeted perioperative outcomes, complication rates, conversion to open surgery, and long-term survival metrics. The GRADE framework was used to assess the quality of included studies and ensure the robustness of evidence.
Results: The analysis incorporated multiple high-quality systematic reviews. Findings suggest that RAS provides significant perioperative advantages, including reduced blood loss, shorter hospital stays, faster recovery, and lower postoperative morbidity compared to conventional open surgery. Oncologic outcomes, such as overall survival and progression-free survival, appear comparable between RAS and traditional surgical approaches. However, the evidence remains limited by study heterogeneity, selection bias, and relatively short follow-up periods in some analyses.
Discussion: The integration of RAS in ovarian cancer surgery offers clear perioperative benefits without compromising oncologic efficacy. However, several challenges remain, including high costs, a steep learning curve for surgeons, limited access in resource-constrained settings, and a lack of long-term oncologic data. Future research should prioritize well-designed randomized controlled trials (RCTs) with extended follow-up periods to solidify the oncologic safety of RAS. Additionally, cost-effectiveness analyses are needed to determine its feasibility for widespread adoption.
Conclusion: Robotic-assisted surgery is a viable and increasingly utilized option for ovarian cancer management. It offers clear perioperative benefits, but further research is needed to confirm its long-term oncologic safety and cost-effectiveness. Clinicians should consider both the advantages and limitations of RAS when selecting the optimal surgical approach for their patients.
Biography
Leen Ibrahim Sabbagh is a fourth-year medical student at Dubai Medical University, UAE, and a core member of the Empowerment Women’s Health Club. She has a strong interest in Obstetrics and Gynecology and has earned Certificates of Excellence in the field. In addition to conducting a literature review on 3D robotics in surgery, she is actively involved in research initiatives aimed at advancing women’s health. Through her work, she strives to enhance surgical precision, reduce risks, and improve patient outcomes while bridging innovation with clinical practice.
Organization Location
1309 Coffeen Avenue, STE 1200, Sheridan, Wyoming 82801, USA
Mail us at
Program Enquiry
healthcaresummit@scientexconferences.com
General Enquiry
contact@scientexconferences.com
Registration Enquiry
finance@scientexconferences.com
healthcaresummit@scientexevents.org
Our Social Presence
Call us at
: (+1) 213 550 1097